The Pharmaceuticals Directory for 381,000 Global Buyers

Product and Services Finder

More

Pharmaceuticals Research Library

DISINFECTION QUALIFICATION TESTING— CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT
ATS Labs
Disinfection qualifications are critical in assuring the microbial control of a manufacturing environment by qualifying the appropriate use and effectiveness of disinfection products and procedures. Obtaining the highest confidence that aseptic, cleanroom, and other critical manufacturing environments are properly cleaned, sanitized and disinfected is paramount in assuring the production of safe ...
 
Successful Product Commercialization
Aptalis Pharmaceutical Technologies
The breadth and depth of our oral technology platforms enables us to combine and adapt the technologies to the drug substance, turning difficult drug candidates into easy-to-administer products for patients. Our expertise lies not only in our proven oral pharmaceutical technologies, but also in our capabilities ranging from formulation development and analytical testing, to small batch ...
 
Non-Steroroidal Cyclooxygenase (COX) Inhibitors
EMD Millipore Bioscience
Cyclooxygenases (COXs), also known as prostaglandin H synthases, are fatty acid oxygenases that contain about 600 amino acid residues and act on arachidonic acid to generate prostaglandins (PG). All vertebrates contain two COX genes: one encoding the constitutive COX-1 and another inducible COX-2. COX-1 and COX-2 share approximately 60-65% amino acid identity. These COX isoforms are bifunctional ...
 
Measuring Pore Sizes in Track-Etched Membranes
Quantachrome Instruments
Liquid expulsion porometry, also known as capillary flow porometry, is ideal for the pore size measurement of track-etched membranes since these materials usually have almost a perfect cylindrical pore structure from one side to the other. This application note describes the results of testing five different track-etched membrane samples using the Quantachrome 3G z porometer.
 
TWINCAPS  A COMMERCIALLY SUCCESSFUL  DISPOSABLE DRY-POWDER INHALER
Hovione Ltd
A COMMERCIALLY SUCCESSFUL DISPOSABLE DRY-POWDER INHALER In September 2005, Biota, the original inventor of zanamivir, the active in GSK’s drug Relenza®, contacted Hovione with the purpose of licensing Hovione’s dry powder inhaler technology for the delivery of a new, long-acting neuraminidase inhibitor for the treatment of influenza. The molecule, CS-8958, was co-owned with Sankyo in Japan and ...
 
SIGN UP FOR OUR
NEWSLETTER
Email
Sign up for our weekly PharmaTech directory newsletter and be the first to know about trending products and services in the lifescience industry.
Aptalis Pharmaceutical Technologies Pharmaceuticals

Pharmaceuticals Video

Biorise Bioavailability Enhancement Technology Aptalis Pharmaceutical Technologies Improved oral bioavailability of poorly soluble compounds resulting in equivalent therapy at lower doses.
 
Site Feasibility Application ePharmaSolutions Presentation on ePharmaSolutions Site Feasibility Application.
 

PharmaTech Features

Wockhardt Products
Quantachrome Instruments Products
Copyright © 2014, Questex Media Group LLC
Company descriptions and contact information are quoted from the company's website or other promotional information. Questex is not responsible for the accuracy of this information. Unless specifically noted, Questex is not sponsored by, affiliated with or otherwise connected with any of the listed companies.